Assessment of the utilization pattern of chemotherapy agents in patients with head and neck cancer in an oncology hospital-Reference-Cited by-同舟云学术

Assessment of the utilization pattern of chemotherapy agents in patients with head and neck cancer in an oncology hospital

Published:2020-04-21 Issue:7 Volume:36 Page:303-309
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

Khadela Avinash,Vyas Bhavin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40267-020-00732-y.pdf

Reference28 articles.

1. World Health Organization. Cancer 2017. https://www.who.int/health-topics/cancer#tab=tab_1. Accessed 04 Dec 2019.

2. International Agency for Research on Cancer. GLOBOCAN, Accessed via Global Cancer Observatory. International Agency for Research on Cancer; 2018. https://www.iarc.fr/wpcontent/uploads/2018/09/pr263_E.pdf. Accessed 04 Dec 2019.

3. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

4. Sharma JD, Baishya N, Kataki AC et al. Head and neck squamous cell carcinoma in young adults: a hospital-based study. Indian J Med Paediatr Oncol 2019;40(Suppl S1):18–22.

5. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people: a comprehensive literature review. Oral Oncol. 2001;37:401–18.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review;Cancer Control;2023-04

2. Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer;Journal of the Egyptian National Cancer Institute;2023-01-19

3. The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens;Technology in Cancer Research & Treatment;2023-01

4. Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects;Technology in Cancer Research & Treatment;2023-01

5. A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer;Medical Oncology;2022-12-30